-
The WHI reports an increase in breast cancer is concentrated in prior hormone users, but the overall adjusted risk of breast cancer is not statistically significant.
-
-
A survey was mailed to 500 members of the American College of Obstetricians and Gynecologists presenting a case of symptomatic fibroids. The respondents were asked to choose hysterectomy or a uterus-sparing procedure, 49% responded.
-
Anderson and colleagues from the WHI performed subgroup analyses focusing on how prior hormone therapy use influenced the risk of breast cancer found in the estrogen-progestin trial arm.
-
The Truth About Multivitamins; Statins and Hepatitis C; Preventing Hot
Flashes; FDA News
-
-
-
The nurses' health study reported the risk of invasive breast cancer associated with the use of combined estrogen and testosterone. At the beginning of this cohort study, only 33 women reported testosterone use, but over the next 10 years this number increased to 550.
-
While stress has well documented effects on immune, neurochemical and endocrinological function, its role in cancer progression is less well understood. It is appreciated, in preclinical studies, that stress can affect the growth of some tumors through modulation of the immune response to tumor cells.
-
Hormone therapy is highly effective for relieving symptoms associated with menopause and for preventing postmenopausal osteoporosis. Some women, however, respond unsatisfactorily to standard doses of hormone therapy.
